Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Ovarian Cancer
Drug:
carboplatin
(
Tubulin polymerization promoter
) +
docetaxel
(
Tubulin polymerization promoter
,
Microtubule stabilizer
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Ovarian cancer: Other Recommended Regimens…Docetaxel/carboplatin Low-grade serous (stage IC)/Grade I endometrioid (stage IC)....Other recommended regimens modified (Also for Stage II-IV disease on OV-C 6 of 11):...Docetaxel/carboplatin ± maintenance letrozole (category 2B) or other hormonal therapy (category 2B)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login